Cost-effectiveness of Escitalopram vs. Venlafaxin XR in the treatment of major depressive disorder in Germany

被引：1
|
作者：
Kulp, W [1 ]
Greiner, W [1 ]
Schulenburg, JM [1 ]
机构：
[1] Univ Hannover, Hannover, Germany
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)63062-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：392 / 393
页数：2
相关论文
共 50 条
  • [31] Escitalopram in major depressive disorder:: clinical benefits and cost effectiveness versus citalopram
    Lancon, Christophe
    Verpillat, Patrice
    Annemans, Lieven
    Despiegel, Nicolas
    Francois, Clement
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (01) : 44 - 52
  • [32] Cost-Effectiveness Evaluation in Sweden of Escitalopram Compared with Venlafaxine Extended-Release as First-Line Treatment in Major Depressive Disorder
    Nordstrom, Goran
    Danchenko, Natalya
    Despiegel, Nicolas
    Marteau, Florence
    VALUE IN HEALTH, 2012, 15 (02) : 231 - 239
  • [33] A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the United Kingdom
    Hemels, ME
    Toumi, I
    Wade, AG
    VALUE IN HEALTH, 2004, 7 (06) : 778 - 778
  • [34] Cost-effectiveness of Olanzapine vs. lithium in bipolar disorder
    Schaerer, LO
    Berns, S
    Born, C
    Brambilla, P
    Dobmeier, M
    Doppmann, T
    Graf, M
    Hartweg, V
    Hasmann, A
    Langosch, J
    Gerber, S
    Malliaris, Y
    Scott, HJ
    Seemüller, F
    Simhandl, C
    Torrent, C
    Trapp, W
    Wolf, J
    Grunze, H
    ACTA PSYCHIATRICA SCANDINAVICA, 2004, 110 : 35 - 35
  • [35] THE COST EFFECTIVENESS OF AGOMELATINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
    Ignatyeva, V
    Avxentyeva, M.
    Frolov, M.
    VALUE IN HEALTH, 2015, 18 (07) : A411 - A411
  • [36] Escitalopram for treatment of major depressive disorder in adults
    Llorca, PM
    Brousse, G
    Schwan, R
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2005, 31 (04): : 490 - 501
  • [37] Cost-Effectiveness of Adjunctive Therapy with Atypical Antipsychotics for Acute Treatment of Major Depressive Disorder
    Taneja, Charu
    Papakostas, George I.
    Jing, Yonghua
    Baker, Ross A.
    Forbes, Robert A.
    Oster, Gerry
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (05) : 642 - 649
  • [38] Escitalopram for the treatment of major depressive disorder in youth
    Ahn, Joon-Ho
    Patkar, Ashwin A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (14) : 2235 - 2244
  • [39] Escitalopram and citalopram in the treatment of major depressive disorder
    Andersen, HF
    Lam, RW
    NORDIC JOURNAL OF PSYCHIATRY, 2005, 59 (05) : 404 - 405
  • [40] The value of a model to consider the cost-effectiveness of interventions for the treatment of major depressive disorder in Canada
    Clement, Fiona
    Kirkham, Julia
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (44) : E1518 - E1519
12345